INSERM, U-912 Economic & Social Sciences, Health Systems & Societies (SE4S), Marseille, F-13273, France.
Crit Rev Oncol Hematol. 2010 Aug;75(2):138-50. doi: 10.1016/j.critrevonc.2009.09.007. Epub 2009 Oct 23.
Advancing age is often associated with co-morbidities. Patients' chronological and physiological ages do not always correspond. Elderly patients are often excluded from clinical trials and given sub-optimum treatment. In this context, the question of equity in access to health care arises. A specially designed questionnaire was mailed to French oncologists to determine what factors influenced them and to elicit their medical practice using four clinical cases. Significant differences in treatment choice depending only on patient's age were observed. The likelihood of an elderly breast cancer patient undergoing chemotherapy was found to depend on physician specialty and gender, kind of care structure, physician's perception of the age at which patients become elderly, and their knowledge about geriatric assessments. Some physicians did not always prescribe potentially beneficial treatments when dealing with elderly patients. Given the multidimensional nature of the care process, patients' preferences should be taken into account in medical decision-making.
随着年龄的增长,常伴有多种合并症。患者的实际年龄和生理年龄并不总是一致的。老年患者通常被排除在临床试验之外,接受次优治疗。在这种情况下,就出现了医疗保健公平性的问题。专门设计的问卷被邮寄给法国肿瘤学家,以确定哪些因素影响他们,并通过四个临床病例引出他们的医疗实践。仅根据患者年龄选择治疗方法存在显著差异。老年乳腺癌患者接受化疗的可能性取决于医生的专业和性别、护理结构类型、医生对患者步入老年的年龄的认知,以及他们对老年评估的了解。一些医生在处理老年患者时并不总是开出潜在有益的治疗方法。鉴于护理过程的多维性质,在医疗决策中应考虑患者的偏好。